A-A-54176
7 June 1990
COMMERCIAL ITEM DESCRIPTION
DIBUCAINE OINTMENT, USP
The General Services Administration has authorized the use of this Commercial Item Description as a replacement for Military Specification MIL-D-37504 which is cancelled.
Salient characteristics.
Shall be Dibucaine Ointment, USP.
Shall be in accordance with the requirements of the USP
Shall contain 1 percent of Dibucaine within the applicable assay limits for the ointment.
All materials entering into the manufacture of the Ointment shall be of pharmaceutical grade.
Workmanship. The products shall be free from defects which detract from its appearance or impair its serviceability.
Unit. Package (PG). Shall be supplied one ounce (28.35 grams) in an ointment tube. One package containing one tube of ointment, together with a suitable rectal applicator, as specified, constitutes one unit.
Contractor certification. The contractor shall certify that the product offered meets the salient characteristics of this description and conforms to the producers’ own drawings, specifications, standards, and quality assurance practices. The Government reserves the right to require proof of such conformance prior to first delivery and thereafter as may be otherwise provided for under the provisions of the contract.
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business